Title : The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.

Pub. Date : 2008 May

PMID : 18294330






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 WHAT THIS STUDY ADDS: This study indicates that the stereoselective pharmacokinetics of fexofenadine are due to P-gp-mediated transport and its stereoselectivity is altered by itraconazole, a an inhibitor of P-gp. fexofenadine ATP binding cassette subfamily B member 1 Homo sapiens
2 WHAT THIS STUDY ADDS: This study indicates that the stereoselective pharmacokinetics of fexofenadine are due to P-gp-mediated transport and its stereoselectivity is altered by itraconazole, a an inhibitor of P-gp. fexofenadine ATP binding cassette subfamily B member 1 Homo sapiens
3 AIMS: The aim of this study was to determine the inhibitory effect of itraconazole, a P-glycoprotein (P-gp) inhibitor, on the stereoselective pharmacokinetics of fexofenadine. fexofenadine ATP binding cassette subfamily B member 1 Homo sapiens
4 AIMS: The aim of this study was to determine the inhibitory effect of itraconazole, a P-glycoprotein (P-gp) inhibitor, on the stereoselective pharmacokinetics of fexofenadine. fexofenadine ATP binding cassette subfamily B member 1 Homo sapiens
5 CONCLUSIONS: This study indicates that the stereoselective pharmacokinetics of fexofenadine are due to P-gp-mediated transport and its stereoselectivity is altered by itraconazole, a P-gp inhibitor. fexofenadine ATP binding cassette subfamily B member 1 Homo sapiens
6 CONCLUSIONS: This study indicates that the stereoselective pharmacokinetics of fexofenadine are due to P-gp-mediated transport and its stereoselectivity is altered by itraconazole, a P-gp inhibitor. fexofenadine ATP binding cassette subfamily B member 1 Homo sapiens